Skip to main content
. 2022 Jun 29;15:5849–5859. doi: 10.2147/IJGM.S366688

Table 1.

Sociodemographic Characteristics of Study Participants

Variable All Participants HAART NAIVE HIV HIV Patients on HAART (n = 157) p-value
Patients (n = 28)
NUMBER OF PARTICIPANTS (%)
Gender 0.815Ϯ
Female 137 (74.1) 20 (71.4) 117 (74.5%)
Male 48 (25.9) 8 (28.6) 40 (25.5%)
Age Category (Years) 0.124Ϯ
18–30 29 (15.7) 8 (28.6) 21 (13.4)
31–40 65 (35.1) 8 (28.6) 57 (36.3)
41 and above 91 (49.2) 12 (42.9) 79 (50.3)
Occupation 0.075Ϯ
Unemployed 39 (21.1) 2 (7.1) 37 (23.6)
Employed 146 (78.9) 26 (92.9) 120 (76.4)
Highest Educational Level 0.775Ϯ
No Education 46 (24.9) 5 (17.9) 41 (26.1)
Basic Education 124 (67.0) 20 (71.4) 104 (66.2)
Senior High School 9 (4.9) 2 (7.1) 7 (4.5)
Tertiary Education 6 (3.2) 1 (3.6) 5 (3.2)
MEDIAN (INTERQUATILE RANGE)
Weight (Kg) 53.0 (46.00–60.00) 53.50 (43.28–63.25) 52.60 (46.00–60.00) 0.812Ѣ
Height (cm) 160.0 (154.00–165.00) 160.00 (154.00–167.25) 160.00 (155.00–164.50) 0.848Ѣ
BMI (Kg/m2) 20.3 (18.00–23.44) 20.89 (17.83–24.83) 20.32 (18.00–23.25) 0.648Ѣ
Respiratory Rate (minutes) 20.00 (19.00–20.00) 20.00 (18.00–21.00) 20.00 (20.00–20.00) 0.997Ѣ
Temperature (℃) 36.40 (36.20–36.50) 36.40 (36.20–36.60) 36.30 (36.20–36.50) 0.221Ѣ

Note: Ϯp-values computed using the chi square test, Ѣp-values computed using the Mann Whitney.

Abbreviations: BMI, body mass Index; HAART, highly active antiretroviral therapy; HIV, human immunodeficiency virus.